Value Based Care Advisory (VBCA) Podcast

The episode densely packs actionable insights about Medicare Advantage contracting, engagement infrastructure as leverage, and the structural reasons commercial healthcare costs 2-4x Medicare rates. Most claims are substantive and differentiated (e.g., the TPA incentive misalignment, supplemental benefit underutilization as revenue loss), though some discussion threads could go deeper and the host occasionally restates rather than probes further.

“Medicare Advantage companies, when I ran one, also own the financial risk we would negotiate hard. Most payers that are working with the large self insured employers...they don't own financial risks, they are just administering a health care benefit.”

“Engagement infrastructure is your leverage point.”

The core thesis - that incentive structure (ownership of risk vs. administration) explains commercial pricing dysfunction - is relatively fresh and counterintuitive for a healthcare podcast. The specific framing of TPA misalignment and the supplemental benefit engagement angle show original thinking, though the Medicare Advantage value proposition itself is well-trodden ground in MA circles.

“So when you have Medicare and Medicare Advantage companies pushing hard when they own the whole medical loss ratio, the financial risk in the Medicare space or the Medicaid space, but then in the commercial space, just acting as a third party administrator, it's not surprising that they're going to push harder in Medicare where they own the risk, then in the commercial space where they don't own the risk.”

“engagement can be done better, cheaper with AI as an ally than it was historically”

Dr. Dharmarajan is exceptionally well-calibrated for this topic: practicing cardiologist, geriatrician, former CMO of Clover Health (scaled MA company), current cofounder/CMO of World Class Health. He has operated at scale in both risk-bearing and clinical contexts, making him a rare practitioner-operator rather than a theorist or fractional advisor.

“He's also a practicing cardiologist and geriatrician. He's a leader who has operated at the intersection of medicine quality measurement and Medicare Advantage executive leadership. He was previously the chief scientific and medical officer at Clover Health”

The episode provides concrete numbers ($15K Medicare vs. $30-60K commercial for knee replacement) and specific examples (gym membership uptake, home-based care for frail seniors, supplemental benefits). However, it lacks named company examples, detailed case studies, or precise engagement metrics that would push this higher. Claims about engagement effectiveness and MA member enrollment percentages (10-20% enrollment) are stated without supporting data.

“If a patient goes to a hospital and let's say has an elective knee replacement procedure, what Medicare will pay? Let's say it's $15,000 for an inpatient procedure. A commercial payer can pay 30, 45, $60,000 for the same procedure”

“Medicare Advantage company may get 10, 15, only 20% of its target members into a program”

The host asks directional questions and provides useful framing/translation of the guest's points for the audience, but rarely pushes back, challenges assumptions, or pursues follow-ups that would test the guest's claims. The host functions more as a translator/interpreter than an investigative partner. Questions are open-ended but not sharp; the dialogue reads more like a seminar than a debate.

“Can you speak a little bit about this?”

“Yeah. So I think many health plans operate in settings with well to do or affluent plan members”